January 2023
- liat mahlev
- Dec 31, 2022
- 1 min read
Updated: Jan 12, 2023
VivaVision and Everads Collaborate to Develop Durable and Effective Therapies for Retinal Diseases. Delivery of VivaVision's best-in-class molecules via the suprachoroidal space using Everads' technology is expected to lead to novel treatments for retinal diseases.
Comments